Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy

Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy

Purpose: The recently reported FLAME trial demonstrated a biochemical disease-free survival benefit to using a focal intraprostatic boost to multiparametric magnetic resonance imaging (mpMRI)–identified lesions in men with localized prostate cancer treated with definitive radiation therapy. Prostate...

Full description

Bibliographic Details
Main Authors: John M. Floberg, MD, PhD, Shane A. Wells, MD, Diane Ojala, CMD, R. Adam Bayliss, PhD, Patrick M. Hill, PhD, Brett A. Morris, MD, PhD, Zachary S. Morris, MD, PhD, Mark Ritter, MD, PhD, Steve Y. Cho, MD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109423000702

Internet

http://www.sciencedirect.com/science/article/pii/S2452109423000702

Similar Items